India to Saudi Arabia: Cyclosporine Export Trade Route
India has recorded 24 verified shipments of Cyclosporine exported to Saudi Arabia, representing a combined trade value of $581.3K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $24.2K USD. The leading Indian exporter is STARCELL BIOTECH LLP, which accounts for 100% of total export value with 21 shipments worth $579.4K USD. On the buying side, M/S ARABIAN OASIS COMPANY is the largest importer in Saudi Arabia with $335.6K USD in purchases. The top 3 suppliers — STARCELL BIOTECH LLP, VEA IMPEX (I) PRIVATE LIMITED, BLUEBERRY HEALTHCARE — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Saudi Arabia Cyclosporine corridor is one of India's established pharmaceutical export routes, with 24 shipments documented worth a combined $581.3K USD. The route is dominated by STARCELL BIOTECH LLP, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's cyclosporine manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $24.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 12.2%, placing it at rank #16 among India's top cyclosporine export destinations globally.
On the import side, key buyers of Indian cyclosporine in Saudi Arabia include M/S ARABIAN OASIS COMPANY, ARABIAN OASIS COMPANY, M S ARABIAN OASIS COMPANY and 3 others. M/S ARABIAN OASIS COMPANY is the single largest importer with 13 shipments valued at $335.6K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#16
- Annual growth+12.2%
- Demand growth+10.8%
- Regulatory ease69/100
Top 10 Indian Cyclosporine Exporters to Saudi Arabia
Showing top 10 of 3 Indian suppliers exporting Cyclosporine to Saudi Arabia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | STARCELL BIOTECH LLP Avg $27.6K per shipment | 21 | $579.4K | 99.7% |
| 2 | VEA IMPEX (I) PRIVATE LIMITED Avg $945 per shipment | 2 | $1.9K | 0.3% |
| 3 | BLUEBERRY HEALTHCARE Avg $20 per shipment | 1 | $20 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting cyclosporine to Saudi Arabia, ranked by total trade value. The listed exporters are: STARCELL BIOTECH LLP, VEA IMPEX (I) PRIVATE LIMITED, BLUEBERRY HEALTHCARE. STARCELL BIOTECH LLP is the dominant supplier with 21 shipments worth $579.4K USD, giving it a 100% market share.
Top 10 Cyclosporine Importers in Saudi Arabia
Showing top 10 of 6 known buyers in Saudi Arabia receiving Cyclosporine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian cyclosporine in Saudi Arabia include M/S ARABIAN OASIS COMPANY, ARABIAN OASIS COMPANY, M S ARABIAN OASIS COMPANY, TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF, among 6 total buyers. The largest importer is M/S ARABIAN OASIS COMPANY, accounting for $335.6K USD across 13 shipments — representing 58% of all cyclosporine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S ARABIAN OASIS COMPANY | 13 | $335.6K | 57.7% |
| 2 | ARABIAN OASIS COMPANY | 5 | $157.3K | 27.1% |
| 3 | M S ARABIAN OASIS COMPANY | 3 | $86.5K | 14.9% |
| 4 | TO THE ORDER OF INVOICE RAISED TO | 1 | $945 | 0.2% |
| 5 | TO THE ORDER OF | 1 | $945 | 0.2% |
| 6 | ARABIC DANAH COMPANY | 1 | $20 | 0.0% |
Top 10 Cyclosporine Formulations Imported by Saudi Arabia
Showing top 10 of 8 product formulations shipped on the India to Saudi Arabia Cyclosporine route, ranked by trade value
Saudi Arabia imports a wide range of cyclosporine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEO — accounts for $447.3K USD across 14 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEO | 14 | $447.3K | 76.9% |
| 2 | CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEORAL 25MG Each Capsule contains Cyclosporine I.P. 25mg 50 soft gelatin capsules | 3 | $86.5K | 14.9% |
| 3 | CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEO | 2 | $41.6K | 7.2% |
| 4 | CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEORAL 100MG (Each Capsule contains Cyclosporine I.P. 100mg) 50 soft gelatin capsul | 1 | $4.0K | 0.7% |
| 5 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - RESTASIS OPTHALMIC EMULS (30 VIALS) CYCLOSPORINE IP | 1 | $945 | 0.2% |
| 6 | RESTASIS OPTHALMIC EMULS (30 VIALS) CYCLOSPORINE IP Batch No-412248 | 1 | $945 | 0.2% |
| 7 | RESTASIS 0.05R DROP CYCLOSPORINE OPHTHALMIC EMULSION 0.05% USP, BATCH NO:402056, | 1 | $20 | 0.0% |
| 8 | FREE SAMPLES ? 96 NUMBERS CYCLOSPORINE C | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 15 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's cyclosporine exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. STARCELL BIOTECH LLP with 21 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — STARCELL BIOTECH LLP, VEA IMPEX (I) PRIVATE LIMITED, BLUEBERRY HEALTHCARE — together account for 100% of total trade value on this route. The average shipment value of $24.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cyclosporine capsules i.p. sandimmun neoral 25mg each capsule contains cyclosporine i.p. 25mg 50 soft gelatin capsules and cyclosporine capsules i.p. sandimmun neo , suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S ARABIAN OASIS COMPANY is the largest importer with 13 shipments worth $335.6K USD — representing 58% of all cyclosporine imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $581.3K
- Avg. Shipment
- $24.2K
- Suppliers
- 3
- Buyers
- 6
- Transit (Sea)
- ~15 days
- Annual Growth
- +12.2%
Related Analysis
Other Cyclosporine Routes
Unlock the Full India to Saudi Arabia Cyclosporine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 24 shipments on this route.
Frequently Asked Questions — India to Saudi Arabia Cyclosporine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Cyclosporine to Saudi Arabia?
The leading Indian exporters of Cyclosporine to Saudi Arabia are STARCELL BIOTECH LLP, VEA IMPEX (I) PRIVATE LIMITED, BLUEBERRY HEALTHCARE. STARCELL BIOTECH LLP holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Cyclosporine exports from India to Saudi Arabia?
India exports Cyclosporine to Saudi Arabia worth approximately $581.3K USD across 24 recorded shipments. The average value per shipment is $24.2K USD.
Q Which ports does India use to ship Cyclosporine to Saudi Arabia?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 15 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Saudi Arabia for Cyclosporine?
The average transit time for Cyclosporine shipments from India to Saudi Arabia is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Saudi Arabia Cyclosporine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.2% with demand growth tracking at 10.8%. The route is ranked #16 among India's top Cyclosporine export destinations globally.
Q How many suppliers are active on the India to Saudi Arabia Cyclosporine route?
There are currently 3 active Indian suppliers exporting Cyclosporine to Saudi Arabia. The market is moderately concentrated with STARCELL BIOTECH LLP accounting for 100% of total shipment value.
Q Who are the main importers of Cyclosporine from India in Saudi Arabia?
The leading importers of Indian Cyclosporine in Saudi Arabia include M/S ARABIAN OASIS COMPANY, ARABIAN OASIS COMPANY, M S ARABIAN OASIS COMPANY, TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF. M/S ARABIAN OASIS COMPANY is the largest buyer with 13 shipments worth $335.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Saudi Arabia export trade corridor identified from Indian Customs (DGFT) records for Cyclosporine.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 6 importers in Saudi Arabia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 24 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
24 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists